MTOR and cancer: In addition to other (possibly unknown) targets, the direct effect on cancer cells is most likely carried out by the inhibition of the AMPK/mTOR pathway [15], and the indirect effect is caused by a combination of the blood glucose-lowering properties, as well as immunological and anti-inflammatory effects [10,14,19,20].